Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Heritable gene targeting in the mouse and rat using a CRISPR-Cas system.
|
Nat Biotechnol
|
2013
|
4.58
|
2
|
High-efficiency and heritable gene targeting in mouse by transcription activator-like effector nucleases.
|
Nucleic Acids Res
|
2013
|
1.61
|
3
|
Deletion of G protein-coupled receptor 48 leads to ocular anterior segment dysgenesis (ASD) through down-regulation of Pitx2.
|
Proc Natl Acad Sci U S A
|
2008
|
1.53
|
4
|
Regulation of bone formation and remodeling by G-protein-coupled receptor 48.
|
Development
|
2009
|
1.50
|
5
|
Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway.
|
Carcinogenesis
|
2010
|
1.44
|
6
|
Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation.
|
Cancer Res
|
2009
|
1.21
|
7
|
Lgr4 regulates mammary gland development and stem cell activity through the pluripotency transcription factor Sox2.
|
Stem Cells
|
2013
|
1.15
|
8
|
Inactivation of G-protein-coupled receptor 48 (Gpr48/Lgr4) impairs definitive erythropoiesis at midgestation through down-regulation of the ATF4 signaling pathway.
|
J Biol Chem
|
2008
|
1.09
|
9
|
A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.
|
Clin Cancer Res
|
2013
|
1.07
|
10
|
GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis.
|
J Cell Biochem
|
2007
|
1.03
|
11
|
Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
|
J Bone Miner Res
|
2011
|
1.03
|
12
|
KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation.
|
J Cell Biochem
|
2009
|
1.03
|
13
|
Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor alpha by inhibiting NF-kappaB signaling pathway.
|
Mol Cancer
|
2010
|
1.02
|
14
|
A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells.
|
PLoS One
|
2012
|
1.00
|
15
|
Lgr4 is a key regulator of prostate development and prostate stem cell differentiation.
|
Stem Cells
|
2013
|
0.97
|
16
|
Lgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expression.
|
J Biol Chem
|
2013
|
0.94
|
17
|
Lgr4-mediated Wnt/β-catenin signaling in peritubular myoid cells is essential for spermatogenesis.
|
Development
|
2013
|
0.92
|
18
|
A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells.
|
Int J Cancer
|
2009
|
0.91
|
19
|
Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-kappaB signaling pathway in colon cancer cells.
|
J Cell Physiol
|
2010
|
0.90
|
20
|
Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis.
|
Cancer Res
|
2011
|
0.90
|
21
|
Regulation of embryonic kidney branching morphogenesis and glomerular development by KISS1 receptor (Gpr54) through NFAT2- and Sp1-mediated Bmp7 expression.
|
J Biol Chem
|
2010
|
0.89
|
22
|
WDR26: a novel Gbeta-like protein, suppresses MAPK signaling pathway.
|
J Cell Biochem
|
2004
|
0.89
|
23
|
Isoalvaxanthone inhibits colon cancer cell proliferation, migration and invasion through inactivating Rac1 and AP-1.
|
Int J Cancer
|
2010
|
0.88
|
24
|
Lgr4 gene deficiency increases susceptibility and severity of dextran sodium sulfate-induced inflammatory bowel disease in mice.
|
J Biol Chem
|
2013
|
0.87
|
25
|
LGR4/GPR48 inactivation leads to aniridia-genitourinary anomalies-mental retardation syndrome defects.
|
J Biol Chem
|
2014
|
0.86
|
26
|
PAK1IP1, a ribosomal stress-induced nucleolar protein, regulates cell proliferation via the p53-MDM2 loop.
|
Nucleic Acids Res
|
2010
|
0.86
|
27
|
Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer.
|
J Transl Med
|
2013
|
0.85
|
28
|
KiSS1 and its G-protein-coupled receptor GPR54 in cancer development and metastasis.
|
Cancer Metastasis Rev
|
2012
|
0.84
|
29
|
A novel human BTB-kelch protein KLHL31, strongly expressed in muscle and heart, inhibits transcriptional activities of TRE and SRE.
|
Mol Cells
|
2008
|
0.83
|
30
|
ZNF411, a novel KRAB-containing zinc-finger protein, suppresses MAP kinase signaling pathway.
|
Biochem Biophys Res Commun
|
2004
|
0.83
|
31
|
Abnormal expression of GADD45B in human colorectal carcinoma.
|
J Transl Med
|
2012
|
0.81
|
32
|
Predictive and prognostic significance of cytoplasmic expression of ELAV-like protein HuR in invasive breast cancer treated with neoadjuvant chemotherapy.
|
Breast Cancer Res Treat
|
2013
|
0.81
|
33
|
Expression of a novel member of sorting nexin gene family, SNX-L, in human liver development.
|
Biochem Biophys Res Commun
|
2002
|
0.80
|
34
|
Inhibition of transcriptional activities of AP-1 and c-Jun by a new zinc finger protein ZNF394.
|
Biochem Biophys Res Commun
|
2004
|
0.80
|
35
|
Lgr4 gene regulates corpus luteum maturation through modulation of the WNT-mediated EGFR-ERK signaling pathway.
|
Endocrinology
|
2014
|
0.80
|
36
|
Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS- regulatory T cells.
|
PLoS One
|
2013
|
0.79
|
37
|
CDK11p58 inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling.
|
BMC Cancer
|
2014
|
0.79
|
38
|
Cudratricusxanthone G inhibits human colorectal carcinoma cell invasion by MMP-2 down-regulation through suppressing activator protein-1 activity.
|
Biochem Pharmacol
|
2011
|
0.78
|
39
|
A novel KRAB zinc-finger protein, ZNF480, expresses in human heart and activates transcriptional activities of AP-1 and SRE.
|
Biochem Biophys Res Commun
|
2004
|
0.78
|
40
|
High sensitivity of touch imprint cytology in young patients with invasive lobular carcinoma of the breast.
|
Tumour Biol
|
2014
|
0.77
|